Hypertension.
Congestive heart failure.
Treatment of patients who within the first few days after an acute myocardial infarction have demonstrated clinical signs of congestive heart failure.
For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularization procedures in patients ≥55 years who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease.
For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularization procedures in diabetic patients ≥55 years with ≥1 of the following risk factors: Systolic blood pressure >160 mm Hg or diastolic blood pressure >90 mm Hg (or on antihypertensive treatment); total cholesterol >5.2 mmol/L; HDL cholesterol <0.9 mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.
Prevention of progressive renal failure in patients with persistent proteinuria.